During this final article our series on multiple sclerosis we're going to re-evaluate treatments for the disease.
Sadly, there's no cure for multiple sclerosis. There are, but, treatments that may hamper the progression of the disease and reduce its effects, so permitting persons full of multiple sclerosis to measure as close to a traditional life as possible. In this article we'll discuss the more general treatments. As a result of multiple sclerosis causes therefore many problems it would be impossible to go over every treatment doable as that might literally take up a whole book.
The treatments available nowadays that are handiest are those that cope with the autoimmune part of multiple sclerosis. These treatments work by regulating the immune system. These are referred to as "ABC" treatments. These are the medication Avonex, Betaseron or Betaferon, and Copaxone. There are actually a pair of more drugs kind of like the higher than 3. They are Rebif and Novantrone. These are still known as the "ABC" treatments because of ease of remembering.
Avonex may be a type of Betainterferon. It is used to treat multiple sclerosis by reducing the average relapse rate in individuals tormented by relapsing remitting multiple sclerosis. Avonex, as a compound, is similar to a naturally occurring protein found in our bodies, that is the explanation why it is effective. It works with our immune system in a a lot of natural way.
Betaseron and Betaferon are very the same as Avonex in that they additionally cut back the common relapse rate in people affected by relapsing remitting multiple sclerosis. The difference is that Betaseron and Betaferon is that it has additionally been shown to scale back EDSS progression and the relapse rate in folks that suffer from secondary progressive multiple sclerosis who are still plagued by relapses.
Copaxone is truly a whole name for a artificial chemical used to change the course of multiple sclerosis. Similar to the medicine discussed higher than, Copaxone conjointly reduces the common relapse rate in people affected by relapsing remitting multiple sclerosis. Additionally it also limits the forming of recent lesions within the central nervous system and reduces brain atrophy.
Copaxone is actually a series of amino acids. Originally, it was designed to mimic a protein in myelin. The intention was to induce EAE, which is an animal model of multiple sclerosis so as to higher perceive a way to treat the human form of this disease. But, the look and also the results were 2 very different things. Copaxone actually had the impact of suppressing the disease. The truth is, a minimum of at this point in time, researchers don't very know how Copaxone works. There is some proof to show that it converts the body's immune response from a th1 sort to a th2 type. Further proof suggests that it might promote suppressor T cells or act as an altered peptide ligand.
Again, there are many treatments for multiple sclerosis and therefore the on top of drugs are just the tip of the iceberg. The MS foundation is making progress daily in finding a cure for this horrible disease. Let us hope and pray that day comes terribly soon.
Author Resource:-
Dorish Hill has been writing articles online for nearly 2 years now. Not only does this author specialize in Diseases Multiple Sclerosis, you can also check out his latest website about:
![[Valid RSS feed]](http://www.healthandwealth4you.com/images/icon_Rss.png "XML Feed For RSS"){kind=icon}
Category Rss Feed
Print This Article
Add To Favorites
